Search

Displaying results 9911 - 9920 of 10000 in total
  1. Drug

    Eritoran

    go.drugbank.com/drugs/DB04933
    Investigational

    Eritoran is a structural analogue of the lipid A portion of lipopolysaccharide (LPS). It is being developed by Eisai Research Institute of Boston for the treatment of severe sepsis.

  2. Drug

    Bupranolol

    go.drugbank.com/drugs/DB08808
    Experimental

    Bupranolol is a non-selective beta blocker with potency similar to propanolol. It does not have intrinsic sympathomimetic activity (ISA), but does have strong membrane stabilizing activity.

  3. Drug

    Lexatumumab

    go.drugbank.com/drugs/DB06599
    Investigational

    Lexatumumab is a fully humanized, high-affinity immunoglobulin G(1 lambda) monoclonal antibody (mAb).

  4. Drug

    Cutamesine

    go.drugbank.com/drugs/DB06618
    Investigational

  5. Drug

    Apoptone

    go.drugbank.com/drugs/DB06307
    Investigational

  6. Drug

    Furaprofen

    go.drugbank.com/drugs/DB06499
    Experimental

  7. Drug

    INCB3284

    go.drugbank.com/drugs/DB05130
    Experimental

    INCB3284 is a CCR2 antagonist for Inflammation-driven Diseases.

  8. Drug

    Praconase

    go.drugbank.com/drugs/DB05584
    Investigational

  9. Drug

    Clevudine

    go.drugbank.com/drugs/DB06683
    Investigational

  10. Drug

    Dexamethasone isonicotinate

    go.drugbank.com/drugs/DB11487
    ExperimentalVet approved

    Dexamethasone isonicotinate is an anti-inflammatory, anti-allergic glucocorticoid that can be administered orally, by inhalation, topically, and parenterally.